The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,412.00
Bid: 4,409.00
Ask: 4,411.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.045%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,412.00
RKT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Senior Independent Director

22 Nov 2023 07:00

RNS Number : 2066U
Reckitt Benckiser Group PLC
22 November 2023
 

ANDREW BONFIELD TO SUCCEED SIR JEREMY DARROCH

AS SENIOR INDEPENDENT DIRECTOR AT 2024 AGM

 

The Board of Reckitt Benckiser Group plc ('Reckitt', the 'Company') is pleased to announce that Andrew Bonfield will succeed Sir Jeremy Darroch as Senior Independent Director, upon Sir Jeremy's appointment as Chair with effect from the Company's Annual General Meeting in May 2024.

 

Andrew Bonfield joined the Board as a Non-Executive Director in July 2018 and was appointed Chair of the Audit Committee in January 2019. Andrew will remain Chair of the Audit Committee and a member of the Nomination Committee following his appointment as Senior Independent Director.

 

This announcement is made in accordance with Listing Rules 9.6.11.

 

CONTACT DETAILS:

 

Contacts

 

Richard Joyce & Hazel Chung +44 (0)7807 418516 / +44 (0)7408 850537

Investor Relations

 

Patty O'Hayer +44 (0)7825 755688

External Relations and Government Affairs

 

FGS

Faeth Birch +44 (0)7768 943171

 

NOTES TO EDITORS:

 

About Andrew Bonfield:

 

Andrew Bonfield was appointed as a Non-Executive Director of Reckitt in July 2018. He is Chair of the Audit Committee and a member of the Nomination Committee. Andrew has been Chief Financial Officer of Caterpillar Inc. since September 2018. He was previously Group CFO of National Grid plc from 2010 to 2018. Prior to this, he held the position of Chief Financial Officer at Cadbury plc and also served as Executive Vice President & Chief Financial Officer at Bristol-Myers Squibb. Andrew is a Chartered Accountant and holds a Bachelor of Commerce degree from the University of KwaZulu-Natal in Durban, South Africa. Andrew brings more than three decades of financial expertise to the Board. He is a strong leader, with experience gained in large, complex organisations and has a history of driving strong financial performance in the UK and globally.

 

About Reckitt:

 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

 

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

 

We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at www.reckitt.com

 

* Reckitt is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOANKDBQDBDBKDB
Date   Source Headline
1st Nov 20222:55 pmRNSTotal Voting Rights
26th Oct 20227:00 amRNS3rd Quarter Results
20th Oct 20224:46 pmRNSHolding(s) in Company
3rd Oct 20222:43 pmRNSTotal Voting Rights
29th Sep 20224:59 pmRNSDirector/PDMR Shareholding
16th Sep 20222:54 pmRNSDirector/PDMR Shareholding
7th Sep 202212:00 pmRNSDirector/PDMR Shareholding
1st Sep 202210:55 amRNSTotal Voting Rights
1st Sep 20227:00 amRNSDirectorate Change
11th Aug 202210:27 amRNSDirectorate Change
5th Aug 202212:07 pmRNSDirector Declaration
1st Aug 20224:07 pmRNSTotal Voting Rights
27th Jul 20227:00 amRNSHalf-year Results
19th Jul 20229:41 amRNSDirector Declaration
1st Jul 20221:34 pmRNSTotal Voting Rights
13th Jun 202211:45 amRNSDirector/PDMR Shareholding
1st Jun 202212:37 pmRNSTotal Voting Rights
23rd May 20225:28 pmRNSDirector/PDMR Shareholding
20th May 20225:30 pmRNSResult of AGM
3rd May 202212:54 pmRNSTotal Voting Rights
29th Apr 20227:00 amRNS1st Quarter Results
27th Apr 20224:29 pmRNSNotice of AGM
14th Apr 202212:26 pmRNSAnnual Financial Report
1st Apr 20221:57 pmRNSTotal Voting Rights
22nd Mar 202212:18 pmRNSDirector/PDMR Shareholding
1st Mar 20223:39 pmRNSTotal Voting Rights
17th Feb 20227:00 amRNSReckitt FY 2021 Results
1st Feb 202210:32 amRNSTotal Voting Rights
17th Jan 20229:00 amRNSDirectorate Change
4th Jan 202211:21 amRNSTotal Voting Rights
24th Dec 20217:00 amRNSProposed Sale of E45 to Karo Pharma
1st Dec 202111:22 amRNSTotal Voting Rights
1st Nov 202111:47 amRNSTotal Voting Rights
26th Oct 202110:01 amRNSDirectorate Change
26th Oct 20217:00 amRNS3rd Quarter Results
4th Oct 20219:35 amRNSDirectorate Change
1st Oct 202111:15 amRNSTotal Voting Rights
23rd Sep 20217:00 amRNSTrading Update & Launch of Investor Seminar Series
16th Sep 20211:20 pmRNSDirector/PDMR Shareholding
9th Sep 20219:24 amRNSClosing sale of IFCN China business to Primavera
1st Sep 202111:08 amRNSTotal Voting Rights
31st Aug 20214:00 pmRNSDirector/PDMR Shareholding
4th Aug 202110:30 amRNSDirector/PDMR Shareholding
3rd Aug 20211:30 pmRNSDirector/PDMR Shareholding
2nd Aug 202112:50 pmRNSTotal Voting Rights
30th Jul 202110:57 amRNSDirector Declaration
29th Jul 20213:30 pmRNSDirector/PDMR Shareholding
28th Jul 20214:00 pmRNSDirector/PDMR Shareholding
28th Jul 202110:00 amRNSDirector/PDMR Shareholding
27th Jul 20217:00 amRNSHalf-Year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.